Laurion Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-499,532
Closed -$50.7M 407
2025
Q4
$50.7M Buy
+499,532
New +$40.1M 1.89% 13
2024
Q4
Sell
-4,326
Closed -$295K 332
2024
Q3
$295K Buy
+4,326
New +$244K ﹤0.01% 232
2019
Q4
Sell
-16,560
Closed -$1.5M 979
2019
Q3
$1.5M Buy
+16,560
New +$1.89M 0.01% 564
2019
Q1
Sell
-22,255
Closed -$1.89M 972
2018
Q4
$1.4M Buy
+22,255
New +$1.53M 0.02% 489
2017
Q3
Sell
-14,200
Closed -$502K 1661
2017
Q2
$502K Buy
+14,200
New +$438K ﹤0.01% 1263
2014
Q4
Sell
-10,100
Closed -$196K 347
2014
Q3
$196K Buy
+10,100
New +$185K ﹤0.01% 266

Other funds holding EXAS

Laurion Capital Management's EXAS Position: Q1 2026 in Review

Laurion Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 499,532 shares — an estimated $50.7M sold.

Laurion Capital Management first reported a position in EXAS in Q3 2014 and held it in 6 quarters. The position peaked at $50.7M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Laurion Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 499,532 Exact Sciences shares in Q1 2026, an estimated $50.7M.
  • Laurion Capital Management first reported a position in Exact Sciences in Q3 2014 and held it in 6 quarters.
  • Laurion Capital Management's Exact Sciences position peaked at $50.7M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.